The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

BD Board Declares Dividend

Tuesday, July 27, 2010

BD Board Declares Dividend14:51 EDT Tuesday, July 27, 2010FRANKLIN LAKES, N.J., July 27 /PRNewswire-FirstCall/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 37 cents per common share, payable on September 30, 2010 to holders of record on September 9, 2010. The indicated annual dividend rate is $1.48 per share. About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit T. White, Corporate Communications ? 201-847-5369Sherry Bertner, Investor Relations ? 201-847-5453SOURCE BD (Becton, Dickinson and Company)For further information: Colleen T. White, Corporate Communications, +1-201-847-5369, or Sherry Bertner, Investor Relations, +1-201-847-5453